May 2004
American Surgeon;May2004, Vol. 70 Issue 5, p387
Academic Journal
Presents comments on the article "Rapamycin Inhibits Release of Tumor Necrosis Factor-α (TNF-α) From Human Vascular Smooth Muscle Cells," by Jonathan R. Adkins and his colleagues. Background on rapamycin; Reason for the comparison of rapamycin to isoproternol on the production of TNF-α; Rationale for using rapamycin in the study.


Related Articles

  • Rapamycin inhibits human in stent restenosis vascular smooth muscle cells independently of pRB phosphorylation and p53. Rosner, Dalya; McCarthy, Nicola; Bennett, Martin // Cardiovascular Research;Jun2005, Vol. 66 Issue 3, p601 

    Abstract: Objective: Drug-eluting stents containing the immunosuppressant rapamycin markedly inhibit in stent restenosis (ISR). However, the molecular mechanisms that underlie its effect on ISR-derived vascular smooth muscle cells (VSMCs), as opposed to normal VSMCs, are unknown. Specifically,...

  • M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis. Guedj, Kevin; Khallou-Laschet, Jamila; Clement, Marc; Morvan, Marion; Gaston, Anh-Thu; Fornasa, Giulia; Dai, Jianping; Gervais-Taurel, Marianne; Eberl, Gerard; Michel, Jean-Baptiste; Caligiuri, Giuseppina; Nicoletti, Antonino // Cardiovascular Research;Mar2014, Vol. 101 Issue 3, p434 

    Aims The goal of this study was to characterize the role of inflammatory macrophages in the induction of the vascular smooth muscle cell (VSMC)-mediated formation of aortic tertiary lymphoid organs (TLOs). Methods and results Mouse bone marrow-derived M1 macrophages acted as lymphoid tissue...

  • In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation. Weiwei Zhu; Masaki, Takahisa; Cheung, Alfred K.; Kern, Steven E. // Journal of Bioequivalence & Bioavailability;May-Jun2009, Vol. 1 Issue 1, p3 

    Hemodialysis arteriovenous grafts are often plagued by stenosis at the anastomosis, which is due to the proliferation of vascular smooth muscle cells (SMCs). To prevent the stenosis, we have been developing a strategy for the sustained perivascular delivery of an antiproliferative agent,...

  • Rapamycin Inhibits Release of Tumor Necrosis Factor-α from Human Vascular Smooth Muscle Cells. Adkins, Jonathan R.; Castresana, Manuel R.; Zhongbiao Wang; Newman, Walter H. // American Surgeon;May2004, Vol. 70 Issue 5, p384 

    Neointimal proliferation with plaque formation is the principal cause of coronary artery disease. In the neointima, inflammatory cytokines like tumor necrosis factor-α (TNF-α) are expressed by vascular smooth muscle cells (VSMCs). These cytokines stimulate proliferation and migration of...

  • BeWo cells stimulate smooth muscle cell apoptosis and elastin breakdown in a model of spiral artery transformation. L.K. Harris; R.J. Keogh; M. Wareing; P.N. Baker; J.E. Cartwright; G.S. Whitley; J.D. Aplin // Human Reproduction;Nov2007, Vol. 22 Issue 11, p2834 

    BACKGROUND During pregnancy, extravillous trophoblast invades the uterine wall and enters the spiral arteries. Remodelling ensues, with loss of vascular smooth muscle cells (SMCs) to create high flow, low resistance vessels. Pregnancies complicated by pre-eclampsia are characterized by...

  • CsA, FK506, corticosteroids and rapamycin inhibit TNFα production by cultured PTEC. Yard, Benito A.; Pancham, Roy R.; Paape, Marion E.; Daha, M. R.; van Es, Leendert A.; van der Woude, Fokko J. // Kidney International;Aug1993, Vol. 44 Issue 2, p352 

    In this study we investigated the effect of immunosuppressive drugs on the interleukin-1 alpha (IL-la) enhanced tumor necrosis factor alpha (TNFα) production by proximal tubular epithelial cells (PTEC). Under basal conditions cultured PTEC produce between 0 to 390 pg/ml/105 cells of TNFα....

  • A Strong Association Between Down-Regulation of HLA-DR Expression and the Late Mortality in Patients with Severe Acute Pancreatitis. Yu-Pin Ho; I-Shyan Sheen; Cheng-Tang Chiu; Cheng-Shyong Wu; Chun-Yen Lin // American Journal of Gastroenterology;May2006, Vol. 101 Issue 5, p1117 

    OBJECTIVES: There is no reliable parameter to predict the late mortality of patients with severe acute pancreatitis though it is an important issue. Recently a proposed parameter for “immunoparalysis,” a down-regulation of Human Leukocytes Antigens-DR (HLA-DR) expression on...

  • Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions. Marzano, A. V.; Ramoni, S.; Del Papa, N.; Barbareschi, M.; Alessi, E. // Lupus;2008, Vol. 17 Issue 4, p329 

    Leflunomide is an immunosuppressive agent that acts by inhibiting pyrimidine synthesis in lymphocytes and other rapidly proliferating cells, as well as by suppressing tumor necrosis factor-α-induced cellular responses. A number of leflunomide-related adverse events have been reported. Among...

  • A Shift towards Pro-Inflammatory CD16+ Monocyte Subsets with Preserved Cytokine Production Potential after Kidney Transplantation. Vereyken, Elly J. F.; Kraaij, Marina D.; Baan, Carla C.; Rezaee, Farhad; Weimar, Willem; Wood, Kathryn J.; Leenen, Pieter J. M.; Rowshani, Ajda T. // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Background: The presence of monocyte-macrophage lineage cells in rejecting kidney transplants is associated with worse graft outcome. At present, it is still unclear how the monocyte-macrophage related responses develop after transplantation. Here, we studied the dynamics, phenotypic and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics